Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
15.53
+0.18 (1.17%)
At close: Aug 21, 2026, 4:00 PM EDT
15.47
-0.06 (-0.42%)
After-hours: Aug 21, 2026, 7:30 PM EDT
Lyell Immunopharma Market Cap
Lyell Immunopharma has a market cap or net worth of $380.56 million as of August 21, 2026. Its market cap has increased by 86.00% in one year.
Market Cap
380.56M
Enterprise Value
199.16M
1-Year Change
86.00%
Ranking
Category
Stock Price
$15.53
ChartMarket Cap Chart
Since the IPO on June 17, 2021, Lyell Immunopharma's market cap has decreased from $4.13B to $380.56M, a decrease of -90.78%. That is a compound annual growth rate of -36.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 380.56M | -41.80% |
| Dec 31, 2025 | 653.89M | 249.70% |
| Dec 31, 2024 | 186.98M | -61.73% |
| Dec 29, 2023 | 488.63M | -43.52% |
| Dec 30, 2022 | 865.16M | -53.52% |
| Dec 31, 2021 | 1.86B | -54.91% |
| Jun 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| X4 Pharmaceuticals | 399.56M |
| Fennec Pharmaceuticals | 398.01M |
| Capricor Therapeutics | 397.38M |
| Clinuvel Pharmaceuticals | 391.00M |
| Enanta Pharmaceuticals | 382.42M |
| Rocket Pharmaceuticals | 382.02M |
| Upstream Bio | 375.18M |
| Century Therapeutics | 365.77M |